Targeted inhibition of tumor proliferation, survival, and metastasis by pentacyclic triterpenoids: potential role in prevention and therapy of cancer - PubMed (original) (raw)
. 2012 Jul 28;320(2):158-70.
doi: 10.1016/j.canlet.2012.02.037. Epub 2012 Mar 7.
Affiliations
- PMID: 22406826
- DOI: 10.1016/j.canlet.2012.02.037
Free article
Targeted inhibition of tumor proliferation, survival, and metastasis by pentacyclic triterpenoids: potential role in prevention and therapy of cancer
Muthu K Shanmugam et al. Cancer Lett. 2012.
Free article
Abstract
Over the last two decades, extensive research on plant-based medicinal compounds has revealed exciting and important pharmacological properties and activities of triterpenoids. Fruits, vegetables, cereals, pulses, herbs and medicinal plants are all considered to be biological sources of these triterpenoids, which have attracted great attention especially for their potent anti-inflammatory and anti-cancer activities. Published reports in the past have described the molecular mechanism(s) underlying the various biological activities of triterpenoids which range from inhibition of acute and chronic inflammation, inhibition of tumor cell proliferation, induction of apoptosis, suppression of angiogenesis and metastasis. However systematic analysis of various pharmacological properties of these important classes of compounds has not been done. In this review, we describe in detail the pre-clinical chemopreventive and therapeutic properties of selected triterpenoids that inhibit multiple intracellular signaling molecules and transcription factors involved in the initiation, progression and promotion of various cancers. Molecular targets modulated by these triterpenoids comprise, cytokines, chemokines, reactive oxygen intermediates, oncogenes, inflammatory enzymes such as COX-2, 5-LOX and MMPs, anti-apoptotic proteins, transcription factors such as NF-κB, STAT3, AP-1, CREB, and Nrf2 (nuclear factor erythroid 2-related factor) that regulate tumor cell proliferation, transformation, survival, invasion, angiogenesis, metastasis, chemoresistance and radioresistance. Finally, this review also analyzes the potential role of novel synthetic triterpenoids identified recently which mimic natural triterpenoids in physical and chemical properties and are moving rapidly from bench to bedside research.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.
Similar articles
- Cancer chemopreventive activity of maslinic acid: suppression of COX-2 expression and inhibition of NF-κB and AP-1 activation in Raji cells.
Hsum YW, Yew WT, Hong PL, Soo KK, Hoon LS, Chieng YC, Mooi LY. Hsum YW, et al. Planta Med. 2011 Jan;77(2):152-7. doi: 10.1055/s-0030-1250203. Epub 2010 Jul 28. Planta Med. 2011. PMID: 20669087 - Multifaceted link between cancer and inflammation.
Sethi G, Shanmugam MK, Ramachandran L, Kumar AP, Tergaonkar V. Sethi G, et al. Biosci Rep. 2012 Feb;32(1):1-15. doi: 10.1042/BSR20100136. Biosci Rep. 2012. PMID: 21981137 Review. - Ursolic acid in cancer prevention and treatment: molecular targets, pharmacokinetics and clinical studies.
Shanmugam MK, Dai X, Kumar AP, Tan BK, Sethi G, Bishayee A. Shanmugam MK, et al. Biochem Pharmacol. 2013 Jun 1;85(11):1579-87. doi: 10.1016/j.bcp.2013.03.006. Epub 2013 Mar 13. Biochem Pharmacol. 2013. PMID: 23499879 - Inhibition of tumor progression by naturally occurring terpenoids.
Kuttan G, Pratheeshkumar P, Manu KA, Kuttan R. Kuttan G, et al. Pharm Biol. 2011 Oct;49(10):995-1007. doi: 10.3109/13880209.2011.559476. Pharm Biol. 2011. PMID: 21936626 Review. - Anti-inflammatory plant natural products for cancer therapy.
Aravindaram K, Yang NS. Aravindaram K, et al. Planta Med. 2010 Aug;76(11):1103-17. doi: 10.1055/s-0030-1249859. Epub 2010 Apr 29. Planta Med. 2010. PMID: 20432202 Review.
Cited by
- Triterpenoid and Steroid Content of Lipophilic Extracts of Selected Medicinal Plants of the Mediterranean Region.
Gadouche L, Alsoufi ASM, Pacholska D, Skotarek A, Pączkowski C, Szakiel A. Gadouche L, et al. Molecules. 2023 Jan 10;28(2):697. doi: 10.3390/molecules28020697. Molecules. 2023. PMID: 36677757 Free PMC article. - Oxidative stress and redox signaling in CRPC progression: therapeutic potential of clinically-tested Nrf2-activators.
Mondal D, Narwani D, Notta S, Ghaffar D, Mardhekar N, Quadri SSA. Mondal D, et al. Cancer Drug Resist. 2021 Mar 19;4(1):96-124. doi: 10.20517/cdr.2020.71. eCollection 2021. Cancer Drug Resist. 2021. PMID: 35582006 Free PMC article. Review. - TRP channels in the skin.
Tóth BI, Oláh A, Szöllősi AG, Bíró T. Tóth BI, et al. Br J Pharmacol. 2014 May;171(10):2568-81. doi: 10.1111/bph.12569. Br J Pharmacol. 2014. PMID: 24372189 Free PMC article. Review. - Clinical significance of Keap1 and Nrf2 in oral squamous cell carcinoma.
Huang CF, Zhang L, Ma SR, Zhao ZL, Wang WM, He KF, Zhao YF, Zhang WF, Liu B, Sun ZJ. Huang CF, et al. PLoS One. 2013 Dec 27;8(12):e83479. doi: 10.1371/journal.pone.0083479. eCollection 2013. PLoS One. 2013. PMID: 24386210 Free PMC article. - Oleanane triterpenoids in the prevention and therapy of breast cancer: current evidence and future perspectives.
Parikh NR, Mandal A, Bhatia D, Siveen KS, Sethi G, Bishayee A. Parikh NR, et al. Phytochem Rev. 2014 Dec;13(4):793-810. doi: 10.1007/s11101-014-9337-5. Phytochem Rev. 2014. PMID: 25395898 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous